Cidara Therapeutics Inc (CDTX)
14.48
+0.58
(+4.17%)
USD |
NASDAQ |
Nov 14, 16:00
14.66
+0.18
(+1.24%)
After-Hours: 20:00
Cidara Therapeutics Gross Profit (Annual): 62.38M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 62.38M |
| Date | Value |
|---|---|
| December 31, 2022 | 64.45M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
62.38M
Minimum
2023
64.45M
Maximum
2022
63.42M
Average
63.42M
Median
Gross Profit (Annual) Benchmarks
| Biomarin Pharmaceutical Inc | 1.904B |
| Arbutus Biopharma Corp | -- |
| GlycoMimetics Inc | -- |
| FibroGen Inc | 128.90M |
| Cue Biopharma Inc | -- |